Nadya Andini

Title: Nadya Andini: Innovator in SARS-CoV-2 Detection Technologies

Introduction

Nadya Andini is a prominent inventor based in Livermore, CA (US). She has made significant contributions to the field of biotechnology, particularly in the detection of SARS-CoV-2. With a total of 2 patents, her work has been instrumental in advancing diagnostic methods for Covid-19.

Latest Patents

Nadya's latest patents focus on polynucleotides for amplification and detection of SARS-CoV-2. These patents disclose primers and probes related to the detection of SARS-CoV-2 via nucleic acid amplification testing (NAAT). Specifically, they describe primers and probes that bind to the N gene, ORF1ab, or E gene of the SARS-CoV-2 coronavirus. This technology is designed for detection via loop-mediated isothermal amplification (LAMP) and molecular beacon hybridization, enabling the amplification and determination of the presence of SARS-CoV-2 in test samples.

Career Highlights

Nadya Andini is currently employed at Talis Biomedical Corporation, where she continues to innovate in the field of molecular diagnostics. Her expertise and dedication to improving public health through technology have made her a valuable asset to her team.

Collaborations

Some of Nadya's notable coworkers include Kathy Chiu and Xuewen Jiang. Their collaborative efforts contribute to the advancement of diagnostic technologies and enhance the impact of their research.

Conclusion

Nadya Andini's work in the field of SARS-CoV-2 detection exemplifies the importance of innovation in biotechnology. Her contributions are vital in the ongoing fight against Covid-19, showcasing the role of inventors in addressing global health challenges.